In summary, we have identified heterozygous variants in KIF5B as a novel cause of osteogenesis imperfecta with a dominant negative mechanism due to an intracellular trafficking defect and downregulation of mTOR signaling pathway. This evidence concerns the gene KIF5B and osteogenesis imperfecta.